Skip to content

Influence of reduction of standard preoperative fasting time and that added with protein in patients with head and neck cancer

Influence of the standard preoperative fasting and added with protein in patients with head and neck cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-63ctjw
Enrollment
Unknown
Registered
2018-05-23
Start date
2018-02-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative complications

Interventions

The population studied will be subdivided into two groups: intervention and control, through randomization stratified by type of surgery. The CHO group is called light tea with 12.5% maltodextrin and
Dietary supplement
SP6.051.227

Sponsors

Instituto Nacional de Câncer
Lead Sponsor
Instituto Nacional de Câncer
Collaborator

Eligibility

Age
19 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients who are candidates for elective surgeries; who are 19 years of age or older; and consent to participate in the study through the signing of the Informed Consent Form.

Exclusion criteria

Exclusion criteria: Volunteers inability to receive oral feeding in the preoperative period; without adherence to any of the phases of the study protocol; in use of prophylactic antiemetics 24 hours before surgery and in the immediate postoperative period; with previous diagnosis of diabetes mellitus, chronic kidney disease and / or liver disease, obesity (WHO, 2000); with presence of gastroesophageal reflux; intestinal obstruction and cases of gastroparesis and / or pyloric stenosis and surgeries with low nutritional impact (base of skull, maxillary sinuses, thyroid gland, parotid glands, cutaneous and ocular).

Design outcomes

Primary

MeasureTime frame
Increased muscle strength in the group receiving CHO-P, compared to the CHO group, around 10% higher, verified by assessment of palmar grip strength.

Secondary

MeasureTime frame
Expected outcome 1: Reduction in response to insulin resistance, measured by the HOMA-IR and QUICKI indices, more effective in the CHO-P group with a difference of p <0.05 in relation to the CHO group. Expected outcome 2: Lower incidence of postoperative complications, assessed by self-collected data sheet, in the CHO-P group compared to the CHO group. There is no expected reduction parameter.

Countries

Brazil

Contacts

Public ContactLeonardo Murad

Instituto Nacional de Câncer

leonardo.murad@inca.gov.br+55 - 21 - 3207 1188

Outcome results

None listed

Source: REBEC (via WHO ICTRP)